INT206699

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 2007
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 6
Total Number 6
Disease Relevance 3.75
Pain Relevance 0.88

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
regulatory T cells 2
saliva 2
cytotoxic T lymphocytes 2
IFN1@ (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 64 100.00 Very High Very High Very High
Multiple sclerosis 29 98.64 Very High Very High Very High
rheumatoid arthritis 10 95.28 Very High Very High Very High
palliative 43 87.60 High High
Arthritis 20 80.20 Quite High
chemokine 5 77.44 Quite High
Inflammation 28 76.72 Quite High
tolerance 9 73.04 Quite High
methotrexate 3 57.00 Quite High
agonist 2 55.28 Quite High
Disease Link Frequency Relevance Heat
Cancer 79 99.98 Very High Very High Very High
Hepatocellular Cancer 58 99.44 Very High Very High Very High
Chlamydia Infection 140 98.66 Very High Very High Very High
Demyelinating Disease 30 98.64 Very High Very High Very High
Toxicity 28 97.80 Very High Very High Very High
Renal Cancer 63 95.80 Very High Very High Very High
Rheumatoid Arthritis 10 95.28 Very High Very High Very High
Metastasis 30 84.96 Quite High
Carcinoma 9 82.80 Quite High
Residual Neoplasm 3 81.48 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A clinically effective therapeutic vaccine to fight viruses or tumour requires the generation and expansion of specific cytotoxic T lymphocytes (CTL) able to proliferate and/or secrete Th1-type cytokines such as IL-2, IFN?
Positive_regulation (requires) of IFN Binding (generation) of in cytotoxic T lymphocytes associated with cancer and cytokine
1) Confidence 0.49 Published 2007 Journal J Immune Based Ther Vaccines Section Body Doc Link PMC1852106 Disease Relevance 0.16 Pain Relevance 0.11
However, the ratio of CD4+CD25high regulatory T cells to IFN-?
Positive_regulation (regulatory T cells) of IFN Binding (ratio) of in regulatory T cells
2) Confidence 0.49 Published 2008 Journal Pediatr Rheumatol Online J Section Body Doc Link PMC2633304 Disease Relevance 0.87 Pain Relevance 0.38
In CT-positive women with fertility disorders, significantly (P < 0.05) lower number of IFN-?
Positive_regulation (lower) of IFN Binding (number) of associated with chlamydia infection
3) Confidence 0.49 Published 2009 Journal Reprod Biol Endocrinol Section Body Doc Link PMC2695819 Disease Relevance 0.82 Pain Relevance 0.03
Despite these limitations, we believe that the current study provides preliminary and powerful data to support future evaluation of SYY in combination with IFN-?
Positive_regulation (support) of IFN Binding (combination) of
4) Confidence 0.49 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2976755 Disease Relevance 0.65 Pain Relevance 0.09
Since bevacizumab has been successfully combined with IFN-?
Positive_regulation (successfully) of IFN Binding (combined) of
5) Confidence 0.49 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.68 Pain Relevance 0.05
In the present study, longitudinal measurement of saliva sHLA-II levels over a six month period demonstrated elevation of saliva sHLA-II levels in association with IFN ?
Positive_regulation (elevation) of IFN Binding (association) of in saliva
6) Confidence 0.45 Published 2007 Journal J Neuroinflammation Section Body Doc Link PMC1939839 Disease Relevance 0.57 Pain Relevance 0.23

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox